BIOXvs its industry peers
A metric-by-metric comparison of BIOX against SIC 2870 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOXEsta | — | — | — | — | — | — | — | — | — | — | — | — |
| SMG | $3.9B#1 | 54.5x#1 | — | 1.1x#3 | -3.9%#2 | 516.0%#1 | 10.5%#1 | — | 12.5%#1 | 6#1 | — | 4.0%#1 |
| CBUS | — | — | — | — | -14.6%#4 | 49.4%#3 | -2680.1%#5 | -858.6%#3 | — | — | — | — |
| AVD | $28M#2 | — | 0.1x#1 | 0.1x#1 | -5.9%#3 | 60.5%#2 | -5.5%#2 | -15.2%#1 | -4.9%#2 | 4#2 | — | — |
| SNES | $6M#3 | — | 1.0x#2 | 2.9x#4 | 19.6%#1 | -3.2%#5 | -292.9%#3 | -105.5%#2 | -390.7%#3 | 3#3 | — | — |
| EVGN | $3M#4 | — | — | 0.8x#2 | -30.9%#5 | 48.5%#4 | -364.2%#4 | — | — | — | — | — |
| NUVI | — | — | — | — | — | -138.3%#6 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2870). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-06.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice